Fasting During Neoadjuvant Chemotherapy
20
about 1.5 years
18+
Female only
1 site in OH
About this study
This trial is testing whether timed fasting during chemotherapy before surgery can be achieved, safe, and improve quality of life compared to standard dietary recommendations for women with epithelial ovarian cancer. Participants will either follow a fasting schedule or receive regular diet advice while undergoing neoadjuvant chemotherapy.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Intermittent Fasting
- 2.Take Neoadjuvant chemotherapy
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Secondary: Chemotherapy related toxicity at Cycle 2, Chemotherapy related toxicity at Cycle 3, Chemotherapy related toxicity at Cycle 4, Chemotherapy related toxicity at post treatment, Post Quality of Life (QLQ-C30) Score Post Treatment, Pre Quality of Life (QLQ-C30) Score at Baseline
Oncology